Broadwood Partners opposes STAAR Surgical sale to Alcon amid proxy concerns
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon
December 16, 2025 7:00 AM ESTISS Says It Would Not Be Unreasonable for a Shareholder to Remain Opposed to the Deal
Broadwood Encourages Shareholders to Follow the Recommendations of Proxy Advisory Firms Glass Lewis and Egan-Jones, Both of Whom Recommend Shareholders Vote AGAINST the Proposed Transaction
NEW YORK--(BUSINESS WIRE)-- Broadwood Partners, L.P. and its affiliates (Broadwood or we) today commented on a report published by Institutional Shareholder Services Inc. (ISS), an independent proxy advisory firm, which reiterates that firms significant concerns regarding the proposed acquisition of STAAR Surgical Company (STAAR or the Company) (NASDAQ:... More
